Total Funding
59
46
Total FundingGrant raised
Growth Score 59 in past quarter
-12 pts
Heat Score 46 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
118409
Orexo is a pharmaceutical company developing improved treatments using proprietary drug delivery technology.
- Dennis Urbaniak: Executive Vice President Digital Therapeutics

About the Company
Orexo develops improved specialty pharmaceuticals and treatments for new areas of use – at a lower cost, in a shorter period of time and at a lower risk – by combining known substances with patented proprietary technologies.

